Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4956
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYildiz, Elif-
dc.contributor.authorTimur, Burcu-
dc.contributor.authorGuney, Gurhan-
dc.contributor.authorTimur, Hakan-
dc.date.accessioned2024-03-25T06:19:14Z-
dc.date.available2024-03-25T06:19:14Z-
dc.date.issued2023-
dc.identifier.citationYildiz, E., Timur, B., Guney, G., Timur, H. (2023). Does the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?. Medicine (Baltimore), 102(20). https://doi.org/10.1097/MD.0000000000033824en_US
dc.identifier.issn0025-7974-
dc.identifier.issn1536-5964-
dc.identifier.urihttp://dx.doi.org/10.1097/MD.0000000000033824-
dc.identifier.urihttps://www.webofscience.com/wos/woscc/full-record/WOS:000995227300025-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4956-
dc.descriptionWoS Categories: Medicine, General & Internalen_US
dc.descriptionWeb of Science Index: Science Citation Index Expanded (SCI-EXPANDED)en_US
dc.descriptionResearch Areas: General & Internal Medicineen_US
dc.description.abstractTo search whether or not the severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) messenger ribonucleic acid (mRNA) vaccine affects the fertility of women at the 6th months by using AMH, which is an ovarian reserve test. Our study, designed as a prospective case-control study, included 104 women who presented to the GOP EAH obstetrics and gynecology outpatient clinic in January and February 2022. The study group included 74 women who presented to the outpatient clinic and planned to be vaccinated and 30 women who refused to be vaccinated as the control group. Anti-COVID-19 antibody levels in all participants were checked before participation in the study, and participants who were positive were excluded from the study. Blood was taken from the participants in both control and study groups to evaluate their AMH levels before the 2 doses of vaccination. After 2 doses of the vaccine, they were called for follow-up, and serological tests were performed to check whether they were positive for anti-COVID-19 antibodies. Participants in both groups were referred for follow-up after 6 months, samples were taken again for AMH, and the data were recorded. The mean age of the study group was 27.6 +/- 5.3 years, and the mean age of the control group was 28.65 +/- 5.25 years (P = .298). There was no statistically significant difference between the vaccinated and nonvaccinated groups in terms of AMH levels measured at the 6th month (P = .970). When the vaccinated group was compared in terms of AMH values at the first visit before vaccination and at the 6th month after vaccination, no statistically significant difference was found between them (p:0.127) mRNA vaccination to protect against SARS-CoV-2 does not adversely affect ovarian reserve, which is an indirect indicator of fertility. mRNA vaccines continue to be the most important method of protection against epidemics. Carefully and accurately informing women who are hesitant to get vaccinated is of great importance for the success of the fight against the epidemic.en_US
dc.language.isoengen_US
dc.publisherLIPPINCOTT WILLIAMS & WILKINS-PHILADELPHIAen_US
dc.relation.isversionof10.1097/MD.0000000000033824en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectanti-mullerian hormone, fertility, mRNA vaccine, ovarian reserve, SARS-CoV-2en_US
dc.subjectCOVID-19en_US
dc.titleDoes the SARS-CoV-2 mRNA vaccine damage the ovarian reserve?en_US
dc.typearticleen_US
dc.relation.journalMEDICINEen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.contributor.authorID0000-0001-8396-5542en_US
dc.contributor.authorID0000-0002-0093-2743en_US
dc.identifier.volume102en_US
dc.identifier.issue20en_US
Appears in Collections:Cerrahi Tıp Bilimleri

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.